{
    "id": "5e324167fbd6abf43b00005a",
    "question": "Is there an increased risk for meningiomas in childhood leukemia survivors?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the available documents and identify any potential relationship between childhood leukemia and the development of meningiomas. According to Document [1], radiation therapy for cancers such as Hodgkin lymphoma is believed to increase the risk of secondary cancers, including myeloid leukemia and meningiomas. Additionally, Document [10] mentions that exposure to radiation therapy for other cancers, including leukemia, may increase the risk of meningiomas. Document [24] states that children who survive childhood leukemia may be at increased risk for developing certain secondary cancers, including meningiomas. Furthermore, Document [28] lists pituitary dysplasia/aplasia, parasellar mass, and craniopharyngioma as potential causes of meningiomas, which are often associated with radiation therapy. Although there is no direct evidence in the provided documents that specifically links childhood leukemia to meningiomas, the available information suggests a potential increased risk for meningiomas in childhood leukemia survivors due to radiation therapy. Therefore, the answer is likely yes, but with the understanding that more research is needed to confirm this association.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "Neurology_Adams_5182",
            "title": "Neurology_Adams",
            "content": "Involvement of the Nervous System in Leukemia Almost one-third of all leukemic patients, especially with childhood leukemia, have evidence of diffuse infiltration of the leptomeninges and cranial and spinal nerve roots at autopsy (Barcos et al). The incidence is greater in acute than in chronic leukemia and greater in lymphocytic than in myelocytic leukemia; it is also as mentioned far more frequent in children than in adults. The highest incidence is in children with acute lymphocytic (lymphoblastic) leukemia who relapse after treatment with combination chemotherapy (60 to 70 percent at time of death). In those cases, the disease in the meninges may be fulminant. The clinical and CSF picture of meningeal leukemia has many similarities to that of meningeal carcinomatosis discussed earlier, with the qualification that leukemic cells are more likely to be found by cytologic examination of the spinal fluid. The treatment of the two disorders is also similar."
        },
        {
            "id": "Pathology_Robbins_1971",
            "title": "Pathology_Robbins",
            "content": "myeloid leukemia, myelodysplastic syndrome, and solid tumors, in individuals who received radiation therapy for cancers such as Hodgkin lymphoma. It is believed that the risk of secondary cancers following irradiation is greatest in children. This is based in part on a large-scale epidemiologic study showing that children who receive at least two CT scans have very small but measurable increased risks for leukemia and malignant brain"
        },
        {
            "id": "Neurology_Adams_5127",
            "title": "Neurology_Adams",
            "content": "Meningiomas also elaborate a variety of soluble proteins, some of which (VEGF) are angiogenic and probably relate to both the highly vascularized nature of these tumors and their prominent surrounding edema (see Lamszus for further details). Some meningiomas contain estrogen and progesterone receptors. These findings may relate to the increased incidence of the tumor in women, its tendency to enlarge during pregnancy, and an association with breast cancer. The precise cellular origin of meningiomas is still not settled. According to Rubinstein, they may arise from dural fibroblasts, but it was the opinion of our colleague"
        },
        {
            "id": "Neurology_Adams_5219",
            "title": "Neurology_Adams",
            "content": "Treatment is predicated on clinical staging, with the lowest risk category allowing observation because some lesions regress spontaneously. Those patients who are at intermediate risk are treated with chemotherapy and high-risk children have surgical resection and receive intensive chemotherapy, radiation, and in selected cases, hematopoietic stem cell transplantation. The two better-risk strata have survival rates exceeding 90 percent, but the highest risk group has a 30 percent survival rate."
        },
        {
            "id": "Pathology_Robbins_5188",
            "title": "Pathology_Robbins",
            "content": "Meningiomas are predominantly benign tumors that arise from arachnoid meningothelial cells. They usually occur in adults and are often attached to the dura. Meningiomas may be found along any of the external surfaces of the brain as well as within the ventricular system, where they arise from the stromal arachnoid cells of the choroid plexus. They often come to attention because of vague nonlocalizing symptoms, or with focal findings referable to compression of adjacent brain. Most meningiomas are easily separable from underlying brain, but some tumors are infiltrative, a feature associated with an increased risk for recurrence. The overall prognosis is determined by the lesion size and location, surgical accessibility, and histologic grade."
        },
        {
            "id": "Neurology_Adams_5142",
            "title": "Neurology_Adams",
            "content": "Several of our cases of meningeal and cranial nerve lymphoma with similar histologic characteristics to primary CNS lymphoma were complications of chronic lymphatic leukemia, a type of so-called Richter transformation. Primary lymphoma involving the cerebral hemispheres initially pursues a clinical course somewhat similar to that of the gliomas but with a vastly different response to treatment. Behavioral and personality changes, confusion, dizziness, and focal cerebral signs predominate over headache and other signs of increased intracranial pressure as presenting manifestations. Seizures may occur but are less common, in our experience, than they are as the introductory feature of gliomas. Most cases occur in adult life, but some have been observed in children, in whom the tumor may simulate the cerebellar symptomatology of medulloblastoma."
        },
        {
            "id": "Pediatrics_Nelson_3300",
            "title": "Pediatrics_Nelson",
            "content": "S166\u2013S171, 2012 Thomas W. McLean and Marcia M. Wofford 21 Childhood cancer is rare; only about 1% of new cancer cases in the United States occur among children younger than 19 years of age. Hematopoietic tumors (leukemia, lymphoma) are the most common childhood cancers, followed by brain/central nervous system (CNS) tumors and sarcomas of soft tissue and bone (Fig. 153-1). There is wide variability in the age-specific incidence of childhood cancers. Embryonal tumors, such as neuroblastoma and retinoblastoma, peak during the first 2 years of life; acute lymphoblastic leukemia peaks during early childhood (ages 2 to 5 years); osteosarcoma peaks during adolescence; and Hodgkin disease peaks during late adolescence (Fig. 153-2). The overall incidence of cancer among white children is higher than that among other ethnic groups and is twice that of African American children in the United States."
        },
        {
            "id": "Pediatrics_Nelson_3309",
            "title": "Pediatrics_Nelson",
            "content": "Genetic conditions Down syndrome is associated with an estimated 10to 20-fold increased risk. Neurofibromatosis 1, Bloom syndrome, and ataxia-telangiectasia, among others, are associated with an elevated risk. Acute myeloid leukemias Chemotherapeutic agents Alkylating agents and epipodophyllotoxins increase risk. Genetic factors Down syndrome and neurofibromatosis 1 are strongly associated. Familial monosomy 7 and several other genetic syndromes are also associated with increased risk. Patients treated with radiation therapy for other cancers. Brain cancers Therapeutic ionizing radiation to the head Genetic factors Neurofibromatosis 1 is strongly associated with optic gliomas and, to a lesser extent, with other central nervous system tumors. Tuberous sclerosis and several other genetic syndromes are associated with increased risk. Hodgkin disease Family history Monozygotic twins and siblings are at increased risk. Infections Epstein-Barr virus is associated with increased risk."
        },
        {
            "id": "Neurology_Adams_5125",
            "title": "Neurology_Adams",
            "content": "Meningiomas represent approximately one-third of all primary intracranial tumors; they are more common in women than in men (2:1) and have their highest incidence in the sixth and seventh decades of life. Some are familial. There is evidence that persons who have undergone radiation therapy to the scalp or cranium are vulnerable to the development of meningiomas and that the tumors appear at an earlier age in such individuals (Rubinstein et al). Radiofrequency energy exposure from portable cellular devices has failed to be linked to elevated incidence of meningiomas (or gliomas). There are also a number of reports of a meningioma developing at the site of previous trauma, such as a cranial fracture line, but the association is uncertain."
        },
        {
            "id": "Pediatrics_Nelson_3332",
            "title": "Pediatrics_Nelson",
            "content": "anemia, Bloom syndrome, ataxia-telangiectasia, Wiskott-Aldrich syndrome, and neurofibromatosis 1 all have an increased risk of acute leukemia. Siblings of children with leukemia are at increased risk of developing leukemia (approximately twofold to fourfold above the childhood population). This risk increases for twin siblings (up to 25% for monozygotic twins). In certain patients with leukemia, the unique antigen receptor gene rearrangement or the specific chromosomal translocation characterizing the patient\u2019s leukemic clone can be demonstrated in cord blood cells and neonatal blood spots used for screening for metabolic diseases, suggesting a possible in utero etiology. There are reports of familial leukemia. Environmental factors that may increase the risk of leukemia include ionizing radiation and exposure to certain chemotherapy agents, particularly the topoisomerase II inhibitors."
        },
        {
            "id": "Neurology_Adams_5187",
            "title": "Neurology_Adams",
            "content": "In addition to radiation injury, important factors in the development of the fulminant syndrome are the age of the patient (many are younger than 5 years old). In an attempt to address the long-term cognitive sequela of cranial radiation in children with leukemia, Pui and coworkers conducted a study and found that it could be safely omitted if all other aspects of therapy have been optimized. Involvement of the Nervous System in Systemic Lymphoma"
        },
        {
            "id": "Neurology_Adams_5181",
            "title": "Neurology_Adams",
            "content": "The median duration of survival after diagnosis of meningeal carcinomatosis was 6 months in the large series reported by Wasserstrom and colleagues, but only 43 days in the series of Sorenson and coworkers. We have experience, however, with individuals who have survived with stable deficits for over a year with breast cancer metastatic to the meninges and lumbar roots. An encephalopathy caused by widespread tumor infiltration or hydrocephalus is a highly concerning and usually preterminal sign. The leukoencephalopathy that follows the combined use of intrathecal methotrexate and radiation therapy is described later. Some patients do not survive long enough for the problem to be manifest. The best response to treatment occurs in patients with lymphoma and breast and small cell lung cancers; cases of meningeal infiltration by other lung cancers, melanoma, and adenocarcinoma do less well. Involvement of the Nervous System in Leukemia"
        },
        {
            "id": "Pediatrics_Nelson_3308",
            "title": "Pediatrics_Nelson",
            "content": "A CBC with differential and review of the peripheral blood smear is the best screening test for many pediatric malignancies. Leukopenia (with or without neutropenia), anemia, or thrombocytopenia may be present in leukemia or any cancer that invades the bone marrow (e.g., neuroblastoma, rhabdomyosarcoma, and Ewing sarcoma). Leukemia may also produce leukocytosis, usually with blasts present on the peripheral blood smear. An isolated cytopenia (neutropenia, anemia, or thrombocytopenia) widens the differential diagnosis but still could be the only abnormal laboratory finding. Of note, a Table 153-1 Known Risk Factors for Selected Childhood Cancers CANCER TYPE RISK FACTOR COMMENTS Acute lymphoid leukemia Ionizing radiation Prenatal diagnostic x-ray exposure increases risk. Therapeutic irradiation for cancer treatment also increases risk."
        },
        {
            "id": "Pediatrics_Nelson_3306",
            "title": "Pediatrics_Nelson",
            "content": "Figure 153-1 Childhood Cancer: SEER Incidence Rates 2005\u20132009 by ICCC Group (includes myelodysplastic syndromes and Group III benign brain). Under 20 years of age, both sexes, all races. Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, and Georgia, excluding ATL/RG). Rates are age-adjusted to the 2000 U.S. Std Population (19 age groups Census P25-1130). International Classification of Childhood Cancer is based on ICD-O-3. (Steliarova-Foucher E, Stiller C, Lacour B, et al: International Classification of Childhood Cancer, ed 3. Cancer 103(7):1457\u22121467, 2005.) *Rate for Group III (Brain/CNS) includes benign brain tumors."
        },
        {
            "id": "InternalMed_Harrison_7930",
            "title": "InternalMed_Harrison",
            "content": "Neurocognitive dysfunction has been well described in childhood survivors of acute lymphoblastic leukemia (ALL) treatment, including intrathecal methotrexate or cytosine arabinoside in conjunction with prophylactic cranial irradiation. Methotrexate alone may cause acute leukoencephalopathy characterized by somnolence and confusion that is often reversible. Acute toxicity is dose related, especially at doses >3 g/m2, with younger patients being at greater risk. Subacute methotrexate toxicity occurs weeks after therapy and is often ameliorated with glucocorticoid therapy. Chronic methotrexate toxicity (leukoencephalopathy) develops months or years after treatment and is characterized clinically as progressive loss of cognitive function and focal neurologic signs, which are irreversible, promoted by synchronous or metachronous radiation therapy, and more pronounced at a younger age."
        },
        {
            "id": "Pediatrics_Nelson_3391",
            "title": "Pediatrics_Nelson",
            "content": "The cause is unknown for most children diagnosed with sarcoma, although a few observations have been made regarding risks. Individuals with Li-Fraumeni syndrome (associated with a germline p53 mutation) and neurofibromatosis (associated with NF1 mutations) have an increased risk of softtissue sarcomas. There is a 500-fold increased risk for osteosarcoma for individuals with hereditary retinoblastoma. Prior treatment for childhood cancer with radiation therapy or chemotherapy, specifically alkylating agents, or both, increases the risk for osteosarcoma as a second malignancy."
        },
        {
            "id": "InternalMed_Harrison_7617",
            "title": "InternalMed_Harrison",
            "content": "Meningiomas arise from the dura mater and are composed of neoplastic meningothelial (arachnoidal cap) cells. They are most commonly located over the cerebral convexities, especially adjacent to the sagittal sinus, but can also occur in the skull base and along the dorsum of the spinal cord. Meningiomas are classified by the WHO into three histologic grades of increasing aggressiveness: grade I (benign), grade II (atypical), and grade III (malignant). Many meningiomas are found incidentally following neuroimaging for unrelated reasons. They can also present with headaches, seizures, or focal neurologic deficits. On imaging studies they have a characteristic appearance usually consisting of a partially calcified, densely enhancing extraaxial tumor arising from the dura (Fig. 118-5). Occasionally they may have a dural tail, consisting of thickened, enhanced dura extending like a tail from the mass. The main differential diagnosis of meningioma is a dural metastasis."
        },
        {
            "id": "Neurology_Adams_4999",
            "title": "Neurology_Adams",
            "content": "For clinicians, several generalizations create a helpful framework for understanding these diseases. First, many types of tumor, both primary and secondary, occur in the cranial cavity and spinal canal but certain ones are much more frequent than others and are prone to occur in particular age groups. For example, secondary metastatic deposits are more common than primary brain tumors in adults and the opposite is true in children. Furthermore, certain cancers (breast, lung, melanoma, renal cell cancer) display a tendency to metastasize to nervous tissue and many others rarely do so. Second, some primary intracranial and spinal tumors, such as craniopharyngioma, meningioma, and schwannoma, have a disposition to grow in particular parts of the cranial cavity, thereby producing characteristic neurologic syndromes. Third, the presence of a state of immunosuppression such as AIDS or cancer chemotherapy, special inherited disorders such as neurofibromatosis, and exposure to radiation each"
        },
        {
            "id": "Neurology_Adams_5429",
            "title": "Neurology_Adams",
            "content": "M\u00f8rk SJ, L\u00f8ken AC: Ependymoma\u2014a follow-up study of 101 cases. Cancer 40:907, 1977. Nevin S: Gliomatosis cerebri. Brain 61:170, 1938. Ojemann RG, Montgomery W, Weiss L: Evaluation and surgical treatment of acoustic neuroma. N Engl J Med 287:895, 1972. Olsen AL, Miller JJ, Bhattacharyya S, et al: Cerebral perfusion in stroke-like migraine attacks after radiation therapy syndrome. Neurology 86:787, 2016. Osborne RH, Houlsen MP, Tijssen CC, et al: The genetic epidemiology of glioma. Neurology 57:1751, 2001. Packer RJ: Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28:823, 1990. Pappas CTE, White WL, Baldree ME: Pituitary tumors: Anatomy, microsurgery, and management. Barrow Neurol Inst Q 6:2, 1990. Partap S, Walker M, Longstreth WT, Spence AM: Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology 66:1105, 2006."
        },
        {
            "id": "Pediatrics_Nelson_3345",
            "title": "Pediatrics_Nelson",
            "content": "Major short-term complications associated with the treatment of leukemia result from bone marrow suppressioncaused by chemotherapy. Patients may have bleeding andsignificant anemia that necessitates transfusion of plateletsor blood. Neutropenia with fewer than 500 neutrophils/mm3, and especially fewer than 100 neutrophils/mm3, greatly predispose the patient to significant bacterial and fungal infection. Cell-mediated immunosuppression increases the risk ofPneumocystis jiroveci (carinii) pneumonia. Prophylaxis withoral trimethoprim-sulfamethoxazole or aerosolized pentamidine is recommended. Prophylaxis with antibiotics andantifungal agents is under investigation. Long-term sequelaeof therapy are less common than in previous treatment erasbut are prevalent in long-term survivors treated in the 1980sand earlier. These sequelae include neurocognitive impairment, short stature, obesity, cardiac dysfunction, infertility,second malignant neoplasms, and psychosocial problems(see Table 154-3)."
        },
        {
            "id": "Neurology_Adams_5432",
            "title": "Neurology_Adams",
            "content": "Pruitt A, Dalmau J, Detre J, et al: Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 67:676, 2006. Pui CH, Campano D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730, 2009. Reid T, Hedegus B, Wechsler-Reya R, Gutman DH: The neurobiology of neurooncology. Ann Neurol 60:3, 2006. Reifenberger G, Louis DN: Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111, 2003. Ribbert H: Geschwulstlehre. Bonn, Verlag Cohen, 1904. Ringertz N: Grading system of gliomas. Acta Pathol Microbiol Scand 27:51, 1950. Robain O, Dulac O, Dommergues JP, et al: Necrotising leukoencephalopathy complicating treatment of childhood leukaemia. J Neurol Neurosurg Psychiatry 47:65, 1984. Ropper AH: Hyperosmolar therapy for raised intracranial pressure. N Engl J Med 367:746, 2012."
        },
        {
            "id": "Neurology_Adams_5430",
            "title": "Neurology_Adams",
            "content": "Partap S, Walker M, Longstreth WT, Spence AM: Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology 66:1105, 2006. Patchell RA, Tibbs PA, Walsh JW, et al: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494, 1990. Pencalet P, Maixner W, Sainte-Rose C, et al: Benign cerebellar astrocytoma in children. J Neurosurg 90:265, 1999. Peterson K, DeAngelis LM: Weighing the benefits and risks of radiation therapy for low-grade glioma. Neurology 56:1225, 2001. Peterson K, Rosenblum MK, Katanider H, Posner JB: Paraneoplastic cerebellar degeneration: I. A clinical analysis of anti-Yo antibody-positive patients. Neurology 42:1931, 1992. Peterson K, Walker RW: Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 45:440, 1995. Pittock SJ, Kryzer TJ, Lennon VA: Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56:715, 2004."
        },
        {
            "id": "Pediatrics_Nelson_3343",
            "title": "Pediatrics_Nelson",
            "content": "and those with T-cell ALL, cranial radiation therapy is usually provided, although the omission of radiation therapy for all pediatric leukemia patients holds great promise. All patients receive continuation therapy for a total duration of therapy of 2 to 3 years. Continuation therapy generally consists of intermittent vincristine and short courses (5 to 7 days) of oral corticosteroid therapy, plus daily oral 6-mercaptopurine, and weekly methotrexate (orally or intramuscularly)."
        },
        {
            "id": "Neurology_Adams_5431",
            "title": "Neurology_Adams",
            "content": "Pittock SJ, Kryzer TJ, Lennon VA: Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56:715, 2004. Plotkin SR, Stermer-Rachaminov AO, Barker FG, et al: Hearing improvement after bevicizumab in patients with neurofibromatosis type 2. N Engl J Med 361:358, 2009. Pollock BE, Huston J: Natural history of asymptomatic colloid cysts of the third ventricle. J Neurosurg 91:364, 1999. Polmeteer FE, Kernohan JW: Meningeal gliomatosis. Arch Neurol Psychiatry 57:593, 1947. Posner J, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19:575, 1978. Posner JB: Primary lymphoma of the CNS. Neurol Alert 5:21, 1987. Price RA, Johnson WW: The central nervous system in childhood leukemia: I. The arachnoid. Cancer 31:520, 1973. Pruitt A, Dalmau J, Detre J, et al: Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 67:676, 2006."
        },
        {
            "id": "Pediatrics_Nelson_3333",
            "title": "Pediatrics_Nelson",
            "content": "Each year 2500 to 3500 new cases of childhood leukemia occur in the United States. The disease affects about 40 per 1 million children under the age of 15 years. ALL accounts for approximately 75% of cases. Acute myelogenous leukemia (AML)accounts for 15% to 20%, and CML accounts for less than 5% of cases. Other chronic leukemias, including juvenile myelomonocytic leukemia, chronic myelomonocytic leukemia, and chronic lymphocytic leukemia, are rare in childhood."
        },
        {
            "id": "Neurology_Adams_5000",
            "title": "Neurology_Adams",
            "content": "neurologic syndromes. Third, the presence of a state of immunosuppression such as AIDS or cancer chemotherapy, special inherited disorders such as neurofibromatosis, and exposure to radiation each predispose to the development of tumors of the nervous system. Fourth, the growth rates and invasiveness of tumors vary; some, like glioblastoma, are highly malignant, invasive, and rapidly progressive and others, like meningioma, are most often benign, slowly progressive, and compressive. These different qualities have substantial clinical implications, frequently providing the explanation of slowly or rapidly evolving clinical states as well as potential surgical cure and prognosis."
        },
        {
            "id": "InternalMed_Harrison_8635",
            "title": "InternalMed_Harrison",
            "content": "In contrast to CLL, acute lymphoid leukemias (ALLs) are predominantly cancers of children and young adults. The L3 or Burkitt\u2019s leukemia occurring in children in developing countries seems to be associated with infection by the Epstein-Barr virus (EBV) in infancy. However, the explanation for the etiology of more common subtypes of ALL is much less certain. Childhood ALL occurs more often in higher socioeconomic subgroups. Children with trisomy 21 (Down\u2019s syndrome) have an increased risk for childhood ALL as well as acute myeloid leukemia (AML). Exposure to high-energy radiation in early childhood increases the risk of developing T-cell ALL. The etiology of ALL in adults is also uncertain. ALL is unusual in middle-aged adults but increases in incidence in the elderly. However, AML is still much more common in older patients. Environmental exposures, including certain industrial exposures, exposure to agricultural chemicals, and smoking, might increase the risk of developing"
        },
        {
            "id": "Pediatrics_Nelson_3367",
            "title": "Pediatrics_Nelson",
            "content": "The therapy for children with CNS tumors is individualized and depends on the tumor type, location, size, and associatedsymptoms. High-dose dexamethasone often is administered immediately to reduce tumor-associated edema. Surgical objectives are complete excision, if possible, and maximal debulkingif a complete excision is not possible. In children, radiationtherapy often is combined with chemotherapy; in young children, radiation therapy may be delayed or avoided altogether.Primitive neuroectodermal tumors (including medulloblastoma) and germ cell tumors are sensitive to chemotherapy; gliomas are less sensitive to chemotherapy. Chemotherapy playsan especially important role, particularly in infants in whomthe effects of high-dose CNS radiation may have devastatingeffects on growth and neurocognitive development."
        },
        {
            "id": "InternalMed_Harrison_26408",
            "title": "InternalMed_Harrison",
            "content": "ETiology of HyPoPiTuiTARiSma Development/structural Transcription factor defect Pituitary dysplasia/aplasia Congenital central nervous system mass, encephalocele Primary empty sella Congenital hypothalamic disorders (septo-optic dysplasia, Prader-Willi syndrome, Laurence-Moon-Biedl syndrome, Kallmann syndrome) Neoplastic Pituitary adenoma Parasellar mass (germinoma, ependymoma, glioma) Rathke\u2019s cyst Craniopharyngioma Hypothalamic hamartoma, gangliocytoma Pituitary metastases (breast, lung, colon carcinoma) Lymphoma and leukemia Meningioma"
        },
        {
            "id": "Pediatrics_Nelson_3370",
            "title": "Pediatrics_Nelson",
            "content": "Improvements in neurodiagnosis, neurosurgical techniques, chemotherapy regimens, and radiation therapy techniques Table 157-1 Location, Incidence, and Prognosis of CNS Tumors in Children LOCATION INCIDENCE (%) 5-YEAR SURVIVAL (%)"
        },
        {
            "id": "Pathology_Robbins_1740",
            "title": "Pathology_Robbins",
            "content": "Fig. 7.32 Sacrococcygealteratoma.Notethesizeofthelesioncomparedwiththatoftheinfant. Table 7.9 Common Malignant Neoplasms of Infancy and Childhood 10\u201314 Years of 0\u20134 Years of Age 5\u20139 Years of Age Age \u2022 Better survival or cure of many childhood tumors, so that much attention is now paid to minimizing the adverse delayed effects of chemotherapy and radiotherapy in survivors, including the development of second malignancies"
        },
        {
            "id": "Pediatrics_Nelson_3361",
            "title": "Pediatrics_Nelson",
            "content": "CNS tumors are the most common solid tumors in children and are second to leukemia in overall incidence during childhood. About 1700 new cases occur each year in the United States; the rate is approximately 33 cases per 1 million children under 15 years of age. The incidence peaks before age 10 years and then decreases until a second peak after age 70. For medulloblastoma and ependymoma, males are more affected than females; for other tumor types, no gender differences exist. In the first 2 to 3 years of life, whites are affected more than multiracial children; otherwise incidence rates are essentially equal for whites and multiracial children. Children with certain inherited syndromes, including neurofibromatosis (types 1 and 2), Li-Fraumeni syndrome, tuberous sclerosis, Turcot syndrome, and von Hippel-Lindau syndrome, have an increased risk for developing a CNS tumor. Most CNS tumors arise in children with no known underlying disorder or risk factor."
        }
    ],
    "scores": [
        0.03422951319070007,
        0.029043295978084034,
        0.024310953559459697,
        0.02340872950809006,
        0.023190161407622086,
        0.022991975744269325,
        0.02246879517629264,
        0.020887476879242556,
        0.019704911667637354,
        0.019049346879535557,
        0.018874643874643875,
        0.018637309292649097,
        0.01834862385321101,
        0.01747674767476748,
        0.0172876304023845,
        0.01716362478777589,
        0.017030473889112635,
        0.01677018633540373,
        0.016420361247947456,
        0.016359508547008548,
        0.015992414664981035,
        0.01598746081504702,
        0.01596617442887795,
        0.01571294559099437,
        0.015390965915791957,
        0.015332099051145569,
        0.01532878344708049,
        0.014877236787349146,
        0.014756944444444444,
        0.014661654135338344,
        0.014656931171480727,
        0.014626594779266535
    ]
}